Key Covid-19 vaccines India banking on-Oxford/AstraZeneca, Novavax | Credit Suisse highlights Aurobindo Pharma, Apollo Hospitals stocks
India needs about 1.7 bn COVID-19 vaccine doses to vaccinate the majority of its adult population. It targets to administer 400-500 mn doses by July 2021. The key vaccines India is banking on are from Oxford/AstraZeneca, Novavax and J&J (temperature range is 2-8°C) and the earliest efficacy data is expected by end of Nov 2020/Dec 2020 and in the best case, vaccines can be rolled out in Jan 2021.
Manufacturing capacity is ample but cold chain infrastructure is key bottleneck: Reuters